Marshall Wace
GRNAW

Marshall Wace’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Marshall Wace’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-328,101
Closed -$761K – 3632
2022
Q3 		$761K Hold
328,101
– – ﹤0.01% 2538
2022
Q2 		$725K Sell
328,101
-1,187
-0.4% -$957 ﹤0.01% 2616
2022
Q1 		$3.17M Buy
329,288
+100,000
+44% +$73.2K 0.01% 1749
2021
Q4 		$2.27M Buy
+229,288
New +$261K ﹤0.01% 1959

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return